It is your plan requiring approval before it will pay for a medication, decided on paperwork your prescriber submits rather than on the prescription itself. Prior authorization for migraine medication is a coverage step rather than a clinical one, which is why a valid prescription can still arrive at a pharmacy and be refused.
Newer preventive classes are where migraine patients meet it most. Our guide to CGRP medications covers one of them.
Medical Disclaimer
This article is general information about United States health insurance processes. It is not medical, legal or insurance advice, and it does not describe your plan. Requirements, forms and timelines differ by plan and by state. Never delay or stop a prescribed treatment because of a coverage problem without speaking to your prescriber.
Quick Answer
Your prescriber submits clinical documentation and the plan decides whether the medication meets its coverage criteria. Those criteria usually involve your diagnosis, your attack frequency, and which treatments you have already tried. A denial is a coverage decision, not a medical judgment, and it can be appealed.
Key Takeaways
- The decision is about payment, not about whether the prescription is appropriate.
- Your prescriber’s office submits it, not you.
- Criteria commonly include diagnosis, frequency and prior treatments tried.
- Documented attack frequency is the single most useful thing you can supply.
- A denial has a stated reason, and the reason determines what to do next.
- A peer-to-peer review lets your prescriber speak to a plan reviewer.
- Delays are common enough to plan around rather than be surprised by.
| Stage | Who acts | What matters |
|---|---|---|
| Prescription written | Prescriber | Nothing yet, the pharmacy may reject it |
| Requirement identified | Pharmacy or plan | Find out which medication triggered it |
| Request submitted | Prescriber’s office | Complete documentation on the first pass |
| Plan review | Plan | Your records against their published criteria |
| Approval | Plan | Note the duration, since it expires |
| Denial | Plan | The stated reason decides your next move |
| Peer-to-peer | Prescriber and plan reviewer | A clinician-to-clinician conversation |
| Appeal | You and prescriber | A separate formal process with deadlines |
What the Plan Is Actually Deciding
HealthCare.gov defines preauthorization as a decision by your health insurer or plan that a service, treatment plan, prescription drug or piece of durable medical equipment is medically necessary.
Read that carefully, because the wording is the whole point. The plan is deciding whether it considers the treatment medically necessary for payment purposes, against criteria it has written.
Your prescriber has already decided the treatment is appropriate for you. Those two judgments are made by different parties using different standards, and they can disagree.
The Centers for Medicare and Medicaid Services describes prior authorization as a utilization management tool used across coverage programs, which is a plain statement of what it is for: controlling what gets paid for.
Understanding that removes a common source of distress. A denial is not a clinician telling you that you do not need the medication.
What Gets Submitted
The request comes from your prescriber’s office, and what goes into it is clinical documentation drawn from your records.
Typical criteria across migraine preventives involve three things: a confirmed diagnosis, your headache frequency, and which treatments you have already tried and how they went.
That third item is where requests stall. A plan asking which preventives you have tried and at what doses needs an answer that exists in the record, not a recollection.
Frequency is where you can genuinely help. A documented count of headache days carries far more weight than an estimate, and it is the figure most likely to decide the outcome.
Our guide to what to record in a migraine diary covers building that record, and our note on chronic against episodic migraine covers the threshold that plan criteria frequently turn on.
Why Migraine Runs Into This So Often
Two features of migraine treatment make prior authorization routine rather than occasional.
The first is cost. Newer preventive classes are considerably more expensive than older options, and expensive categories attract utilization management.
The second is the availability of cheaper alternatives. Where older medications exist for the same indication, plans build criteria around trying those first.
Injectable and procedural treatments add their own layer, since administration and site of care come into the decision. Our roundup of Botox alternatives for chronic migraine covers a category where documentation requirements are well known to patients.
Acute treatment meets it too, often as a quantity limit rather than an outright requirement. Our guide to how triptans work covers a class where monthly quantity restrictions are common.
The American Medical Association has documented prior authorization as a source of treatment delay and administrative burden on practices, which is worth knowing because it explains why your prescriber’s office may be slow rather than unwilling.
Timelines and What Delay Means for You
Plans operate under decision deadlines, and those differ between standard and expedited requests and between coverage types.
The practical figure is not the deadline but the elapsed time, which includes your prescriber’s office gathering documentation and submitting it. That part is often longer than the plan’s own review.
An expedited review exists where waiting would jeopardize your health, and asking whether your situation qualifies is reasonable rather than pushy.
In the meantime, the question for your prescriber is what you do about treatment now. Samples, a bridging prescription, or a different medication are all normal answers, and the one thing to avoid is going without a plan.
Approvals also expire. Note the duration when one comes through, because a lapse produces the same pharmacy rejection months later.
What to Do When It Is Denied
- Get the reason in writing. Plans must state it, and it determines everything after.
- Read whether it is criteria or paperwork. Missing documentation is a resubmission, not a fight.
- Ask about a peer-to-peer review. Your prescriber speaking to a plan reviewer resolves a fair number.
- Check whether a step therapy rule caused it. That has its own exception process.
- Supply the frequency record. If a count was missing, this is where it goes.
- Start the formal appeal if needed. It is a separate process with its own deadlines.
- Keep treating in the meantime. Agree an interim plan with your prescriber rather than pausing.
Our guide to preparing for an appointment covers arriving with what the request will need, and our list of questions to ask a neurologist covers asking about coverage barriers before a prescription is written.
Related Reading
Frequently Asked Questions
What is prior authorization for migraine medication?
Your plan requiring approval before it will pay for a medication. HealthCare.gov describes it as a decision by your insurer that a treatment is medically necessary. Your prescriber submits clinical documentation, the plan reviews it against published criteria, and the outcome governs payment rather than whether the prescription is appropriate.
Who submits it, me or my doctor?
Your prescriber’s office submits the request, drawing on your medical records. What you can usefully contribute is documentation, particularly a record of headache days and of which treatments you have already tried, since incomplete prior-treatment history is a common reason requests stall.
What criteria do plans use?
Commonly a confirmed diagnosis, your headache frequency, and which treatments you have tried and how they went. The specific criteria are the plan’s own and are usually published, so asking for the criteria applied to your request is a reasonable request.
How long does it take?
Plans work to decision deadlines that differ between standard and expedited requests, but the elapsed time you experience also includes your prescriber’s office gathering and submitting documentation, which is frequently the longer part. Ask whether your situation qualifies for expedited review.
What should I do while I wait?
Agree an interim plan with your prescriber rather than going without. Samples, a bridging prescription, or a different medication in the meantime are all normal. The thing to avoid is treating a coverage delay as a reason to stop treatment without medical input.
Does a denial mean I do not need the medication?
No, and this distinction matters. A denial is a coverage decision made against the plan’s payment criteria, not a clinician’s judgment that the treatment is inappropriate. Your prescriber has already made the clinical decision, and the two judgments use different standards.
What is a peer-to-peer review?
A conversation between your prescriber and a clinician reviewer at the plan, where the clinical reasoning can be explained directly rather than through a form. It resolves a meaningful share of denials and is worth asking your prescriber’s office to request.
When should I see a doctor rather than chasing the plan?
Clinical questions, interim treatment and peer-to-peer requests go to your prescriber. Questions about which criteria were applied, what documentation is missing, and how to appeal go to the plan. For anything about your own treatment, your prescriber comes first.
Sources
- HealthCare.gov. Glossary: preauthorization.
- Centers for Medicare and Medicaid Services. Prior authorization and utilization management.
- American Medical Association. Prior authorization burden and treatment delays.
